Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
Sustained Virologic Response
MeSH Descriptor Data 2025
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Sustained Virologic Response
Tree Number(s)
E01.789.800.570
N04.761.559.590.800.665
N05.715.360.575.575.800.665
Unique ID
D000072230
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000072230
Scope Note
The continuous, long-term suppression of
VIRAL LOAD
, generally to undetectable levels, as the result of treatment with
ANTIVIRAL AGENTS
.
Entry Term(s)
Sustained Viral Suppression
Previous Indexing
Antiviral Agents/therapeutic use (1999-2016)
Drug Therapy, Combination (1999-2016)
Treatment Outcome (1999-2016)
Public MeSH Note
2017
History Note
2017
Date Established
2017/01/01
Date of Entry
2016/07/08
Revision Date
2016/05/27
No Qualifiers
Diagnosis [E01]
Prognosis [E01.789]
Treatment Outcome [E01.789.800]
Disease-Free Survival [E01.789.800.190]
Early Termination of Clinical Trials [E01.789.800.238]
Pathologic Complete Response [E01.789.800.262]
Progression-Free Survival [E01.789.800.285]
Response Evaluation Criteria in Solid Tumors [E01.789.800.379]
Sustained Virologic Response [E01.789.800.570]
Therapeutic Index [E01.789.800.665]
Treatment Expectations [E01.789.800.713]
Treatment Failure [E01.789.800.760]
Health Services Administration [N04]
Quality of Health Care [N04.761]
Outcome and Process Assessment, Health Care [N04.761.559]
Outcome Assessment, Health Care [N04.761.559.590]
Treatment Outcome [N04.761.559.590.800]
Disease-Free Survival [N04.761.559.590.800.190]
Early Termination of Clinical Trials [N04.761.559.590.800.379]
Pathologic Complete Response [N04.761.559.590.800.427]
Progression-Free Survival [N04.761.559.590.800.474]
Response Evaluation Criteria in Solid Tumors [N04.761.559.590.800.569]
Sustained Virologic Response [N04.761.559.590.800.665]
Therapeutic Index [N04.761.559.590.800.713]
Treatment Expectations [N04.761.559.590.800.737]
Treatment Failure [N04.761.559.590.800.760]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Outcome and Process Assessment, Health Care [N05.715.360.575]
Outcome Assessment, Health Care [N05.715.360.575.575]
Treatment Outcome [N05.715.360.575.575.800]
Disease-Free Survival [N05.715.360.575.575.800.190]
Early Termination of Clinical Trials [N05.715.360.575.575.800.379]
Pathologic Complete Response [N05.715.360.575.575.800.427]
Progression-Free Survival [N05.715.360.575.575.800.474]
Response Evaluation Criteria in Solid Tumors [N05.715.360.575.575.800.569]
Sustained Virologic Response [N05.715.360.575.575.800.665]
Therapeutic Index [N05.715.360.575.575.800.713]
Treatment Effect Heterogeneity [N05.715.360.575.575.800.737]
Treatment Expectations [N05.715.360.575.575.800.749]
Treatment Failure [N05.715.360.575.575.800.760]
Expand All
Collapse All
Sustained Virologic Response
Preferred
Concept UI
M000616660
Scope Note
The continuous, long-term suppression of
VIRAL LOAD
, generally to undetectable levels, as the result of treatment with
ANTIVIRAL AGENTS
.
Terms
Sustained Virologic Response
Preferred Term
Term UI
T000898728
Date
04/11/2016
LexicalTag
NON
ThesaurusID
NLM (2017)
Sustained Viral Suppression
Term UI
T000898729
Date
04/11/2016
LexicalTag
NON
ThesaurusID
NLM (2017)
page delivered in 0.146s